Angiodynamics (ANGO) Change in Accured Expenses (2010 - 2026)

Angiodynamics has reported Change in Accured Expenses for 17 years, with the latest figure at -$6.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 45.17% year-over-year to -$6.0 million; the trailing twelve-month figure through Feb 2026 stood at -$10.9 million (down 42.43% YoY), and the FY2025 full-year result was -$15.9 million, down 157.67% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$6.0 million, down from $3.2 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $17.7 million in Q1 2024, with the low at -$16.5 million in Q3 2023.
• Historically, Change in Accured Expenses has averaged $511176.5 across 5 years, with a median of $2.6 million in 2025.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 446.88% — and 2024, when it soared 515.14%.
• Angiodynamics' Change in Accured Expenses stood at $6.1 million in 2022, then surged by 153.34% to $15.6 million in 2023, then sank by 51.97% to $7.5 million in 2024, then tumbled by 57.48% to $3.2 million in 2025, then plunged by 289.06% to -$6.0 million in 2026.
• The last three Change in Accured Expenses figures came in at -$6.0 million (Q1 2026), $3.2 million (Q4 2025), and -$10.7 million (Q3 2025), per Business Quant data.